This study will address if red blood cells transfused to a sickle cell patient from a donor with a glucose-6-phosphate-dehydrogenase (G6PD) enzyme deficiency have a different lifespan as measured by the percentage of red blood cells that survive post-transfusion compared to red blood cells transfused to a sickle cell patient from a donor without a G6PD enzyme deficiency.
David Wichlan | |
919-966-6876 | |
[email protected] |
18 Years - 60 Years
Phase 2
Interventional
All
Biological
Age 18-60 years
Has diagnosis of sickle cell disease
Steady state (no pain or baseline pain and ≥1 month from any hospital admission)
Receiving chronic transfusions (i.e., regular transfusion every 4-8 weeks).
History of transfusion reactions not adequately managed by antihistamines
Does not have crossmatch compatible red cells
Known G6PD deficiency
Hepato- or splenomegaly
Participation in another therapeutic trial
Pregnant or nursing
HIV positive
At investigator discretion for uncontrolled inter-current illness or social situation limiting compliance with study requirements.
Inability to speak and/or read English